Search Tag: TNBC

2024 18 Apr

  The stiffness of triple-negative breast tumours influences the aggressiveness of cancer cells and their ability to spread to other organs, according to research from the Garvan Institute of Medical Research. Soft tumour environments prime cancer cells for survival during metastasis by triggering an alternative form of metabolism. A recent study...Read more

2024 18 Apr

  The stiffness of triple-negative breast tumours influences the aggressiveness of cancer cells and their ability to spread to other organs, according to research from the Garvan Institute of Medical Research. Soft tumour environments prime cancer cells for survival during metastasis by triggering an alternative form of metabolism. A recent study...Read more

2022 11 Jan

Cleveland Clinic researchers along with Anixa Biosciences have initiated a phase 1 clinical trial to test a vaccine intended to prevent triple-negative breast cancers (TNBC). This trial is a first of its kind.   TNBCs are named so because they test negative for estrogen receptors, progesterone receptors, and excess HER2 protein. Since these are...Read more